HIMS & Health (To him -15.90%)) Stocks fell from 9.2%to 11:40 am from the bad news from Texas’s great states on Thursday morning.
The US District Court in the northern Texas has just made a ruling in a lawsuit related to GLP-1 weight loss drugs, and the ruling has a negative effect on him and her business.
All Texas News suitable for printing
The story is as follows: The Outsourcing Facilies Association or OFA in the center of Texas filed a lawsuit against the FDA to prevent the FDA from saying that there is no no longer lack of Tirjeipid. Ellie LilySepbound weight loss drug -like Semaglutide, it is active ingredient. Novo Nordic‘s ozempic.
This tribe is essential to allow drug complexes, such as OFA (and HIMS & HERS Health), can create and sell their GLP-1 drugs. In short, if it is insufficient, HIMS & HERS (and OFA) can continue to sell GLP-1 drugs that imitate Lilly’s drugs. But if you say that the FDA is finished, you can’t do it. And when the FDA declared the end of the Semagluide tribe last month, ending with Tir’s pethide tribe can erect him.
Well, today District Court ruled that OFA could not force FDA. No ~ It says that the tribe is over. It means FDA I can do it Tell the tribe Be above.
This means that he and her health
There is no ban on the Texas lawsuit, but today, as the FDA is already called the end of the Oz Big tribe, there is no ban to say that the tribe of Jeff is over. Therefore, there is a real risk that the situation can be called by the FDA to end with all GLP-1 tribes. If that happens, it is highly likely that HIMS & HERS’s future GLP-1 sales are difficult and stocks will be hit hard.
In fact, it is already as we are looking at today.
Rich Smith has no location in any of the shares mentioned. MOTLEY FOOL recommends Novo Nordisk. The MOTLEY FOOL has a public policy.
